Tran, D., Ghiaseddin, A., Campian, J., Staal, S., Andrews, S., Warren, S., & Ansstas, G. (2017). ACTR-29. A PHASE 2 STUDY OF TTFIELDS AND PULSED BEVACIZUMAB IN PATIENTS WITH BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA. Neuro Oncol.
Chicago-tyylinen lähdeviittausTran, David, Ashley Ghiaseddin, Jian Campian, Stephen Staal, Sarah Andrews, Sonisha Warren, ja George Ansstas. "ACTR-29. A PHASE 2 STUDY OF TTFIELDS AND PULSED BEVACIZUMAB IN PATIENTS WITH BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA." Neuro Oncol 2017.
MLA-viiteTran, David, et al. "ACTR-29. A PHASE 2 STUDY OF TTFIELDS AND PULSED BEVACIZUMAB IN PATIENTS WITH BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA." Neuro Oncol 2017.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.